Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Express Scripts
Moodys
Baxter
Fuji
Healthtrust
Julphar
Daiichi Sankyo

Generated: November 21, 2018

DrugPatentWatch Database Preview

Toremifene citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for toremifene citrate and what is the scope of toremifene citrate freedom to operate?

Toremifene citrate is the generic ingredient in one branded drug marketed by Kyowa Kirin and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for toremifene citrate. One supplier is listed for this compound.

Pharmacology for toremifene citrate
Medical Subject Heading (MeSH) Categories for toremifene citrate
Synonyms for toremifene citrate
(Z)-2-(4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate
(Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine Citrate
(Z)-2-[4-(4-chloro-1,N- dimethylethanamine, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
(Z)-4-Chloro-1-(4-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene Citrate
(Z)-4-Chloro-1,2-diphenyl-1-(4-(2-(N,N-dimethylamino)ethoxy)phenyl)-1-butene citrate (1:1)
2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
2-(p-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1)
2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine citrate (1:1)
2-[4-(4-chloro-1,2-diphenylbut-1-en-1-yl)phenoxy]-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate(1:1)
2-[4-[(Z)-4-chloranyl-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine; 2-oxidanylpropane-1,2,3-tricarboxylic acid
2-[4-[(Z)-4-chloro-1,2-diphenyl-but-1-enyl]phenoxy]-N,N-dimethyl-ethanamine; citric acid
2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid
2-[p-[(Z)-4-Chloro-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethylethylamine citrate (1:1)
2-[p-[(Z)-4-chloro-1,N- dimethylethylamine citrate (1:1)
2-{4-[4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
2498Y783QT
778T267
89778-26-7 (Parent)
89778-27-8
A843307
AB2000287
AC-1985
AC1MHJ30
AC1Q5SNQ
AK139145
AKOS015888270
AN-14397
BB_SC-4133
BC215662
BG0531
CAS-89778-27-8
CCG-101072
CCRIS 6719
CHEBI:9636
CHEMBL1200675
citro; toremifene
CPD000469213
CS-1272
D00967
DR003354
DSSTox_CID_1367
DSSTox_GSID_21367
DSSTox_RID_76113
DTXSID2021367
Ethanamine, 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
Fareston
Fareston;Acapodene
FC 1157a
HMS2052C03
HMS2230P09
HMS3264L11
HY-B0005
I01-1039
IWEQQRMGNVVKQW-OQKDUQJOSA-N
KM2865
KS-5242
LS-64922
MLS001306432
MLS006011608
NC00322
NCGC00255310-01
NK 622
NSC 613680
NSC-613680
NSC-759190
NSC613680
NSC759190
Pharmakon1600-01505682
s1776
S962
SAM001246774
SCHEMBL4564
SMR004703372
ST24050182
TL8005784
Toremifene (Citrate)
Toremifene Citrate (Fareston, Acapodene)
Toremifene citrate (JAN/USAN)
Toremifene citrate [USAN]
Toremifene citrate salt, >=98% (HPLC)
Tox21_111877
Tox21_301740
UNII-2498Y783QT

US Patents and Regulatory Information for toremifene citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kyowa Kirin FARESTON toremifene citrate TABLET;ORAL 020497-001 May 29, 1997 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Express Scripts
Moodys
Baxter
Fuji
Healthtrust
Julphar
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.